Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPG | P10696 | 10/20 | 0.64 |
| ▸ | ALPL | P05186 | 8/20 | 0.64 |
| ▸ | NSD2 | O96028 | 5/20 | 0.52 |
| ▸ | GAA | P10253 | 4/20 | 0.52 |
| ▸ | PLAA | Q9Y263 | 6/20 | 0.51 |
| ▸ | POLB | P06746 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | GFER | P55789 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | ALPI | P09923 | 3/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7208414 | 0.83 | GRIN2B (0.47) | ALPGALPLGAAPOLBKDM4E | |
| SCHEMBL7207863 | 0.81 | ALDH1A1 (0.46) | ALPGALPLNSD2GAAKDM4E | |
| SCHEMBL6400119 | 0.78 | CYP19A1 (0.44) | ALPGALPLPOLBKDM4EALDH1A1 | |
| SCHEMBL6399622 | 0.78 | TSHR (0.52) | GAAKDM4EALDH1A1KMT2AMEN1 | |
| SCHEMBL6396604 | 0.78 | KMT2A (0.62) | KDM4EALDH1A1MAPTKMT2AMEN1 | |
| SCHEMBL6398248 | 0.78 | ALDH1A1 (0.57) | POLBKDM4EALDH1A1MAPTKMT2A | |
| SCHEMBL9356659 | 0.77 | ALPG (0.70) | ALPGALPLNSD2GAAPLAA | |
| SCHEMBL6399913 | 0.75 | MGAM (0.44) | GAAKDM4EALDH1A1MAPTKMT2A | |
| SCHEMBL6400029 | 0.75 | ALDH1A1 (0.65) | POLBKDM4EALDH1A1MAPTKMT2A | |
| SCHEMBL7388115 | 0.74 | ALPL (0.48) | ALPGALPLGAAPLAAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050004092-A1 | Penem derivatives and antimicrobial agent containing the same | DAIICHI SUNTORY PHARMA CO., LTD. (JP) | 2005-01-06 | — | — | US | disclosed |
| EP-0757051-B1 | PENEM DERIVATIVES AND ANTIMICROBIAL AGENT CONTAINING THE SAME | DAIICHI SUNTORY PHARMA CO LTD (JP) | 2003-10-29 | — | — | EP | disclosed |
| EP-0757051-A1 | PENEM DERIVATIVES AND ANTIMICROBIAL AGENT CONTAINING THE SAME | SUNTORY LIMITED (JP) | 1997-02-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050004092-A1 | Penem derivatives and antimicrobial agent containing the same | MRPL21, MRPS2, MRPS28 | ALPG 3369/4885ALPL 1957/4885NSD2 2747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.